title: Chromogranin A blood concentrations in relation to those of prolactin in hormone-refractory metastatic prostate cancer: possible existence of two independent mechanisms responsible for endocrine resistance.
authors.forename: P
authors.initials: P
authors.lastname: Lissoni
authors.forename: P
authors.initials: P
authors.lastname: Viganò
authors.forename: A
authors.initials: A
authors.lastname: Podraska
authors.forename: R
authors.initials: R
authors.lastname: Brivio
authors.forename: M
authors.initials: M
authors.lastname: Colciago
authors.forename: M
authors.initials: M
authors.lastname: Casu
authors.forename: V
authors.initials: V
authors.lastname: Manganini
authors.forename: C
authors.initials: C
authors.lastname: Giuberti
authors.forename: G
authors.initials: G
authors.lastname: Strada
authors.forename: G
authors.initials: G
authors.lastname: Gardani
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D053379:Chromogranin A; D002864:Chromogranins / Q000097:blood*; D019008:Drug Resistance, Neoplasm; D006801:Humans; D008297:Male; D008875:Middle Aged; D009376:Neoplasms, Hormone-Dependent / Q000097:blood; D011388:Prolactin / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood*
chemical_list: C506150:CHGA protein, human; D053379:Chromogranin A; D002864:Chromogranins; D011388:Prolactin